Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum
- 31 December 2003
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 28 (3), 275-283
- https://doi.org/10.1016/s1386-6532(03)00022-2
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Epstein-Barr Virus (EBV) DNA in Sera of Patients with Primary EBV InfectionJournal of Clinical Microbiology, 2001
- Pediatric Solid-Organ Transplant Recipients Carry Chronic Loads of Epstein-Barr Virus Exclusively in the Immunoglobulin D-Negative B-Cell CompartmentJournal of Clinical Microbiology, 2001
- Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignanciesBritish Journal of Haematology, 2000
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER LOCALIZED NEAR THE ALLOGRAFT IN RENAL TRANSPLANTATIONTransplantation, 2000
- Use of rituximab and irradiated donor-derived lymphocytes to control Epstein–Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantationBone Marrow Transplantation, 1999
- Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantationBritish Journal of Haematology, 1999
- EBER in situ hybridisation: Sensitive detection of latent Epstein‐Barr virus in individual cellsReviews in Medical Virology, 1994
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaNew England Journal of Medicine, 1989